160 related articles for article (PubMed ID: 10420980)
41. TMPRSS11A activates the influenza A virus hemagglutinin and the MERS coronavirus spike protein and is insensitive against blockade by HAI-1.
Zmora P; Hoffmann M; Kollmus H; Moldenhauer AS; Danov O; Braun A; Winkler M; Schughart K; Pöhlmann S
J Biol Chem; 2018 Sep; 293(36):13863-13873. PubMed ID: 29976755
[TBL] [Abstract][Full Text] [Related]
42. Cleavage of influenza virus hemagglutinin by airway proteases TMPRSS2 and HAT differs in subcellular localization and susceptibility to protease inhibitors.
Böttcher-Friebertshäuser E; Freuer C; Sielaff F; Schmidt S; Eickmann M; Uhlendorff J; Steinmetzer T; Klenk HD; Garten W
J Virol; 2010 Jun; 84(11):5605-14. PubMed ID: 20237084
[TBL] [Abstract][Full Text] [Related]
43. Role of host trypsin-type serine proteases and influenza virus-cytokine-trypsin cycle in influenza viral pathogenesis. Pathogenesis-based therapeutic options.
Kido H; Takahashi E; Kimoto T
Biochimie; 2019 Nov; 166():203-213. PubMed ID: 31518617
[TBL] [Abstract][Full Text] [Related]
44. Hemagglutinin Stability Regulates H1N1 Influenza Virus Replication and Pathogenicity in Mice by Modulating Type I Interferon Responses in Dendritic Cells.
Russier M; Yang G; Briard B; Meliopoulos V; Cherry S; Kanneganti TD; Schultz-Cherry S; Vogel P; Russell CJ
J Virol; 2020 Jan; 94(3):. PubMed ID: 31694942
[TBL] [Abstract][Full Text] [Related]
45. Activation of influenza viruses by proteases from host cells and bacteria in the human airway epithelium.
Böttcher-Friebertshäuser E; Klenk HD; Garten W
Pathog Dis; 2013 Nov; 69(2):87-100. PubMed ID: 23821437
[TBL] [Abstract][Full Text] [Related]
46. Modifications to the hemagglutinin cleavage site control the virulence of a neurotropic H1N1 influenza virus.
Sun X; Tse LV; Ferguson AD; Whittaker GR
J Virol; 2010 Sep; 84(17):8683-90. PubMed ID: 20554779
[TBL] [Abstract][Full Text] [Related]
47. Novel type II transmembrane serine proteases, MSPL and TMPRSS13, Proteolytically activate membrane fusion activity of the hemagglutinin of highly pathogenic avian influenza viruses and induce their multicycle replication.
Okumura Y; Takahashi E; Yano M; Ohuchi M; Daidoji T; Nakaya T; Böttcher E; Garten W; Klenk HD; Kido H
J Virol; 2010 May; 84(10):5089-96. PubMed ID: 20219906
[TBL] [Abstract][Full Text] [Related]
48. Secretory leukoprotease inhibitor and pulmonary surfactant serve as principal defenses against influenza A virus infection in the airway and chemical agents up-regulating their levels may have therapeutic potential.
Kido H; Okumura Y; Yamada H; Mizuno D; Higashi Y; Yano M
Biol Chem; 2004 Nov; 385(11):1029-34. PubMed ID: 15576322
[TBL] [Abstract][Full Text] [Related]
49. Role of hemagglutinin cleavage for the pathogenicity of influenza virus.
Steinhauer DA
Virology; 1999 May; 258(1):1-20. PubMed ID: 10329563
[TBL] [Abstract][Full Text] [Related]
50. Tmprss2 knock-out mice are resistant to H10 influenza A virus pathogenesis.
Lambertz RLO; Gerhauser I; Nehlmeier I; Leist SR; Kollmus H; Pöhlmann S; Schughart K
J Gen Virol; 2019 Jul; 100(7):1073-1078. PubMed ID: 31099738
[TBL] [Abstract][Full Text] [Related]
51. Inhibition of influenza virus infection in human airway cell cultures by an antisense peptide-conjugated morpholino oligomer targeting the hemagglutinin-activating protease TMPRSS2.
Böttcher-Friebertshäuser E; Stein DA; Klenk HD; Garten W
J Virol; 2011 Feb; 85(4):1554-62. PubMed ID: 21123387
[TBL] [Abstract][Full Text] [Related]
52. Endogenous protease-dependent replication of human influenza viruses in two MDCK cell lines.
Noma K; Kiyotani K; Kouchi H; Fujii Y; Egi Y; Tanaka K; Yoshida T
Arch Virol; 1998; 143(10):1893-909. PubMed ID: 9856079
[TBL] [Abstract][Full Text] [Related]
53. TMPRSS2 Activates Hemagglutinin-Esterase Glycoprotein of Influenza C Virus.
Sato K; Hayashi H; Shimotai Y; Yamaya M; Hongo S; Kawakami K; Matsuzaki Y; Nishimura H
J Virol; 2021 Oct; 95(21):e0129621. PubMed ID: 34406864
[TBL] [Abstract][Full Text] [Related]
54. Human matriptase/ST 14 proteolytically cleaves H7N9 hemagglutinin and facilitates the activation of influenza A/Shanghai/2/2013 virus in cell culture.
Whittaker GR; Straus MR
Influenza Other Respir Viruses; 2020 Mar; 14(2):189-195. PubMed ID: 31820577
[TBL] [Abstract][Full Text] [Related]
55. Potentiation of infectivity and pathogenesis of influenza A virus by a house dust mite protease.
Akaike T; Maeda H; Maruo K; Sakata Y; Sato K
J Infect Dis; 1994 Oct; 170(4):1023-6. PubMed ID: 7930699
[TBL] [Abstract][Full Text] [Related]
56. Antibody against the carboxyl terminus of the F2 subunit of Sendai virus fusion glycoprotein inhibits proteolytic activation.
Tashiro M; Takeda M; Tanaka S; Nishimura N; Takenaka M; Kido H
Virology; 1993 Jun; 194(2):882-5. PubMed ID: 8389088
[TBL] [Abstract][Full Text] [Related]
57. Hemagglutinin activating host cell proteases provide promising drug targets for the treatment of influenza A and B virus infections.
Böttcher-Friebertshäuser E; Lu Y; Meyer D; Sielaff F; Steinmetzer T; Klenk HD; Garten W
Vaccine; 2012 Dec; 30(51):7374-80. PubMed ID: 23072892
[TBL] [Abstract][Full Text] [Related]
58. Proteolytic activation of the 1918 influenza virus hemagglutinin.
Chaipan C; Kobasa D; Bertram S; Glowacka I; Steffen I; Tsegaye TS; Takeda M; Bugge TH; Kim S; Park Y; Marzi A; Pöhlmann S
J Virol; 2009 Apr; 83(7):3200-11. PubMed ID: 19158246
[TBL] [Abstract][Full Text] [Related]
59. Proteolytic activation of influenza viruses by serine proteases TMPRSS2 and HAT from human airway epithelium.
Böttcher E; Matrosovich T; Beyerle M; Klenk HD; Garten W; Matrosovich M
J Virol; 2006 Oct; 80(19):9896-8. PubMed ID: 16973594
[TBL] [Abstract][Full Text] [Related]
60. Influenza viruses, cell enzymes, and pathogenicity.
Rott R; Klenk HD; Nagai Y; Tashiro M
Am J Respir Crit Care Med; 1995 Oct; 152(4 Pt 2):S16-9. PubMed ID: 7551406
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
